AVENUE THERAPEUTICS, INC. (ATXI) › Cash & EquivalentsAVENUE THERAPEUTICS, INC. (ATXI) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2015: $14.0K2016: $197.0K2017: $11.78M2018: $2.67M2019: $8.74M2020: $3.13M2021: $3.76M2022: $6.71M2023: $1.78M2024: $2.59M2025: $2.85M$2.85M2015Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$2.85M+10.1%2024$2.59M+45.5%2023$1.78M-73.4%2022$6.71M+78.3%2021$3.76M+20.1%2020$3.13M-64.2%2019$8.74M+227.4%2018$2.67M-77.3%2017$11.78M+5880.7%2016$197.0K+1307.1%2015$14.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share